Provesicles as Novel Drug Delivery Systems

被引:15
|
作者
Bayindir, Zerrin S. [1 ]
Yuksel, Nilufer [1 ]
机构
[1] Ankara Univ, Fac Pharm, Dept Pharmaceut Technol, TR-06100 Ankara, Turkey
关键词
Administration routes; characterization; provesicles; proliposomes; proniosomes; vesicular systems; IN-VIVO EVALUATION; ENHANCED INTESTINAL-ABSORPTION; MALTODEXTRIN-BASED PRONIOSOMES; NONIONIC SURFACTANT VESICLES; LOADED NEUTRAL PROLIPOSOMES; IMPROVED ORAL DELIVERY; VITRO SKIN PERMEATION; TRANSDERMAL DELIVERY; CANCER-THERAPY; BIOAVAILABILITY ENHANCEMENT;
D O I
10.2174/1389201016666150206101443
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vesicular systems exhibit many attractive properties such as controlled drug release, ability to carry both hydrophilic and hydrophobic drugs, targetability and good biocompatibility. With these unique properties they can provide improved drug bioavailability and reduced side effects. Until now, many vesicular formulations have been studied in clinical and preclinical stages. Nevertheless, the major concern about these systems is their low physicochemical stability and high manufacturing expenses. The stability problems (fusion, aggregation, sedimentation, swelling, and drug leakage during storage) associated with the aqueous nature of vesicular systems hinders their effective usage. The advances on improving the stability of vesicular systems led to the emergence of provesicular systems, which are commonly described as dry, free flowing pre-formulations of vesicular drug delivery systems. Provesicles form vesicular systems upon hydratation with water and exhibit the advantages of vesicular systems with improved stability. The present article briefly reviews vesicular systems (particularly liposomes and niosomes) and enlightens about the innovations in the field. Overall investigations are reviewed and the provesicle approach is explained by giving detailed information on the composition, preparation, administration and characterization methods of provesicular systems (proliposomes and proniosomes). The scope of this article is expected to give insight to the researchers and industrialists to perform further research in this area.
引用
收藏
页码:344 / 364
页数:21
相关论文
共 50 条
  • [31] Novel Drug Delivery Systems: Future Directions
    Berkowitz, Angelia Colwell
    Goddard, Diane M.
    JOURNAL OF NEUROSCIENCE NURSING, 2009, 41 (02) : 115 - 120
  • [32] Polymers as novel drug delivery systems.
    Uhrich, KE
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U292 - U292
  • [33] Novel drug delivery systems in pain therapy
    Al Malyan, M.
    Becchi, C.
    Boncinelli, S.
    Ashammakhi, N.
    MINERVA ANESTESIOLOGICA, 2007, 73 (03) : 173 - 179
  • [34] Self-nanoemulsifying drug delivery systems as novel approach for pDNA drug delivery
    Hauptstein, Sabine
    Pruefert, Felix
    Bernkop-Schnuerch, Andreas
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 487 (1-2) : 25 - 31
  • [35] Topical Delivery of Aceclofenac: Challenges and Promises of Novel Drug Delivery Systems
    Raza, Kaisar
    Kumar, Manish
    Kumar, Pramod
    Malik, Ruchi
    Sharma, Gajanand
    Kaur, Manmeet
    Katare, O. P.
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [36] Application of Novel Biomaterials in Colloidal Drug Delivery Systems
    M. C. Garnett
    S. Stolnik
    S. E. Dunn
    I. Armstrong
    Wu Lin
    E. Schacht
    P. Ferutti
    M. Vert
    M. C. Davies
    L. Illum
    S. S. Davis
    MRS Bulletin, 1999, 24 (5) : 49 - 56
  • [37] Novel Drug Delivery Systems for the Management of Fungal Keratitis
    Ruan, Mengyu
    Wang, Ruiqing
    He, Yuxi
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2024, 40 (03) : 160 - 172
  • [38] Novel drug delivery systems, devices, and fabrication methods
    Agrahari, Vivek
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2018, 8 (02) : 303 - 306
  • [39] Novel Central Nervous System Drug Delivery Systems
    Stockwell, Jocelyn
    Abdi, Nabiha
    Lu, Xiaofan
    Maheshwari, Oshin
    Taghibiglou, Changiz
    CHEMICAL BIOLOGY & DRUG DESIGN, 2014, 83 (05) : 507 - 520
  • [40] Novel drug delivery systems with magnetic properties.
    Noveron, JC
    Cruz-Campa, I
    Santiago, L
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U1454 - U1454